全文获取类型
收费全文 | 2988篇 |
免费 | 361篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 131篇 |
妇产科学 | 58篇 |
基础医学 | 359篇 |
口腔科学 | 84篇 |
临床医学 | 396篇 |
内科学 | 513篇 |
皮肤病学 | 192篇 |
神经病学 | 209篇 |
特种医学 | 172篇 |
外科学 | 323篇 |
综合类 | 146篇 |
一般理论 | 1篇 |
预防医学 | 354篇 |
眼科学 | 61篇 |
药学 | 241篇 |
中国医学 | 1篇 |
肿瘤学 | 98篇 |
出版年
2022年 | 21篇 |
2021年 | 56篇 |
2020年 | 27篇 |
2019年 | 60篇 |
2018年 | 63篇 |
2017年 | 42篇 |
2016年 | 64篇 |
2015年 | 52篇 |
2014年 | 75篇 |
2013年 | 97篇 |
2012年 | 123篇 |
2011年 | 119篇 |
2010年 | 87篇 |
2009年 | 91篇 |
2008年 | 124篇 |
2007年 | 135篇 |
2006年 | 134篇 |
2005年 | 118篇 |
2004年 | 113篇 |
2003年 | 104篇 |
2002年 | 112篇 |
2001年 | 127篇 |
2000年 | 109篇 |
1999年 | 86篇 |
1998年 | 63篇 |
1997年 | 46篇 |
1996年 | 34篇 |
1995年 | 37篇 |
1994年 | 44篇 |
1993年 | 44篇 |
1992年 | 58篇 |
1991年 | 42篇 |
1990年 | 63篇 |
1989年 | 73篇 |
1988年 | 69篇 |
1987年 | 50篇 |
1986年 | 40篇 |
1985年 | 45篇 |
1984年 | 41篇 |
1983年 | 24篇 |
1982年 | 20篇 |
1981年 | 25篇 |
1979年 | 29篇 |
1978年 | 23篇 |
1976年 | 24篇 |
1974年 | 31篇 |
1973年 | 28篇 |
1972年 | 27篇 |
1971年 | 21篇 |
1967年 | 24篇 |
排序方式: 共有3361条查询结果,搜索用时 46 毫秒
91.
92.
93.
Williams Rachel C. Dawson Deborah A. Horsburgh Gavin J. Sinclair William 《Conservation Genetics Resources》2015,7(1):107-111
Conservation Genetics Resources - A microsatellite-enriched genomic library was created from a single Nautilus pompilius individual and clones/fragments sequenced using Sanger and Illumina MiSeq... 相似文献
94.
95.
The combination of high-dose busulfan (16 mg/kg) and 200 mg/kg cyclophosphamide is gaining increasing significance as a preparative regimen prior to autologous, syngeneic, or allogeneic marrow transplantation. A new regimen of high-dose busulfan in conjunction with a reduced dose of 120 mg/kg cyclophosphamide has recently been described as a preparative regimen prior to allogeneic transplantation. To determine the drug-related nonhematologic toxic effects of this new regimen without confounding factors associated with allogeneic transplantation, we conducted a pilot study using this new regimen in 20 patients with acute myeloid leukemia (AML) in first remission prior to autologous unpurged marrow transplantation. All patients experienced transient non-life-threatening acute drug-related toxicity with skin reactions in 20 (100%), nausea and vomiting in 20 (100%), oral mucositis in 18 (90%), hepatic functional impairment in 17 (85%), hemorrhagic cystitis in three (15%), and generalized seizures in two (10%) of these patients, respectively. Two procedural, fatal complications resulted from infectious causes that were not directly related to the speed of hematopoietic reconstitution or the toxicity of the preparative regimen. The 3-year event-free survival estimate (55% +/- 11%) and probability of leukemic recurrence (38% +/- 11%) attained with this new regimen in recipients of autografts in first remission of AML are promising and challenge comparisons with preparative regimens employing combinations of cytotoxic agents or total body irradiation (TBI). 相似文献
96.
The present study examined the effect of a relatively nonselective opioid antagonist, naloxone, on lever pressing for oral ethanol by the alcohol-preferring AA rats. The AAs, housed continually in operant chambers with free access to food and water, learned to respond for 10% oral ethanol during daily 60-min alcohol access periods indicated by a stimulus light. The rats developed stable ethanol responding, resulting in mean ethanol intakes of 1.2 g/kg/60 min and measurable blood alcohol levels. In the first experiment, single systemic injections of naloxone (0.05–2.5 mg/kg) had no effect on the initial rate of responding; dose-dependent decreases were observed later during the alcohol access. The second experiment examined the effects of repeated injections of 0.5 and 2.5 mg/kg naloxone on 5 consecutive days. Naloxone suppressed responding dose-relatedly over the treatment days. In contrast to the effects of single injections, repeated injections with 2.5 mg/kg naloxone produced progressive decreases within the first minutes of access. The results suggest that naloxone may attenuate the reinforcing actions of ethanol. 相似文献
97.
98.
Hunt PW Brenchley J Sinclair E McCune JM Roland M Page-Shafer K Hsue P Emu B Krone M Lampiris H Douek D Martin JN Deeks SG 《The Journal of infectious diseases》2008,197(1):126-133
BACKGROUND: Although untreated human immunodeficiency virus (HIV)-infected patients maintaining undetectable plasma HIV RNA levels (elite controllers) have high HIV-specific immune responses, it is unclear whether they experience abnormal levels of T cell activation, potentially contributing to immunodeficiency. METHODS: We compared percentages of activated (CD38(+)HLA-DR(+)) T cells between 30 elite controllers, 47 HIV-uninfected individuals, 187 HIV-infected individuals with undetectable viremia receiving antiretroviral therapy (antiretroviral therapy suppressed), and 66 untreated HIV-infected individuals with detectable viremia. Because mucosal translocation of bacterial products may contribute to T cell activation in HIV infection, we also measured plasma lipopolysaccharide (LPS) levels. RESULTS: Although the median CD4(+) cell count in controllers was 727 cells/mm(3), 3 (10%) had CD4(+) cell counts <350 cells/mm(3) and 2 (7%) had acquired immunodeficiency syndrome. Controllers had higher CD4(+) and CD8(+) cell activation levels (P < .001 for both) than HIV-negative subjects and higher CD8(+) cell activation levels than the antiretroviral therapy suppressed (P = .048). In controllers, higher CD4(+) and CD8(+) T cell activation was associated with lower CD4(+) cell counts (P = .009 and P = .047). Controllers had higher LPS levels than HIV-negative subjects (P < .001), and in controllers higher LPS level was associated with higher CD8(+) T cell activation (P = .039). CONCLUSION: HIV controllers have abnormally high T cell activation levels, which may contribute to progressive CD4(+) T cell loss even without measurable viremia. 相似文献
99.
100.